Home  /  Resource Library  /  How does COVID-19 impact patients with lymphoma receiving B-cell-depleting immunotherapy?

How does COVID-19 impact patients with lymphoma receiving B-cell-depleting immunotherapy?

EHA 2021: Video interview with Caroline Besson, MD who dicusses the impact of COVID-19 on patients with lymphoma receiving anti CD20 immunochemotherapy.